Status:
COMPLETED
Effects of Carboxymethylcellulose Artificial Tears on the Eye Microbiome
Lead Sponsor:
University of Florida
Conditions:
Dry Eye Syndromes
Eligibility:
All Genders
18-100 years
Phase:
PHASE4
Brief Summary
Carboxymethylcellulose (CMC), a common component in artificial tears, has been shown to modify the gut microbiome. The study is examining its effects on the eye microbiome, which may have implications...
Eligibility Criteria
Inclusion
- Adults above age 18 of either sex who can self-administer artificial tears and return for follow-up at the UF Oaks Eye Clinic.
Exclusion
- Individuals with active eye infections or have prosthetic eyes.
- Are immunocompromised, or are diagnosed with autoimmune diseases or malignant neoplasms about the eye.
- Individuals who take immunomodulatory therapy, steroids, antibiotics, medicated eyedrops, or are already using CMC eyedrops within 1 week of the study will also be excluded.
Key Trial Info
Start Date :
April 22 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2022
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05292755
Start Date
April 22 2022
End Date
July 1 2022
Last Update
April 20 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Florida Oaks Eye Center
Gainesville, Florida, United States, 32605